Cargando…

Cell-specific mineralocorticoid receptors: future therapeutic targets for stroke?

Detalles Bibliográficos
Autores principales:	Dinh, Quynh N., Drummond, Grant R., Sobey, Christopher G., Chrissobolis, Sophocles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2016
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020814/ https://www.ncbi.nlm.nih.gov/pubmed/27651763 http://dx.doi.org/10.4103/1673-5374.189173

Ejemplares similares

Aldosterone and the mineralocorticoid receptor in the cerebral circulation and stroke
por: Dinh, Quynh N, et al.
Publicado: (2012)

Roles of Inflammation, Oxidative Stress, and Vascular Dysfunction in Hypertension
por: Dinh, Quynh N., et al.
Publicado: (2014)

Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress
por: Dinh, Quynh Nhu, et al.
Publicado: (2017)

Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis
por: Tesch, Greg H., et al.
Publicado: (2017)

Mineralocorticoid Receptor–Mediated Vascular Insulin Resistance: An Early Contributor to Diabetes-Related Vascular Disease?
por: Bender, Shawn B., et al.
Publicado: (2013)

Interfering with mineralocorticoid receptor activation: the past, present, and future
por: Dorrance, Anne M.
Publicado: (2014)

The Cardiac Mineralocorticoid Receptor (MR): A Therapeutic Target Against Ventricular Arrhythmias
por: Rossier, Michel F.
Publicado: (2021)

Therapeutic targeting of mineralocorticoid receptors in pulmonary hypertension: Insights from basic research
por: Mamazhakypov, Argen, et al.
Publicado: (2023)

Molecular mechanisms of NMDA receptor-mediated excitotoxicity: implications for neuroprotective therapeutics for stroke
por: Li, Victor, et al.
Publicado: (2016)

Identification of mineralocorticoid receptor target genes in the mouse hippocampus
por: van Weert, Lisa T. C. M., et al.
Publicado: (2019)

Mineralocorticoid receptor antagonist in heart failure: Past, present and future perspectives
por: Vizzardi, Enrico, et al.
Publicado: (2014)

Biomolecular Self-Defense and Futility of High-Specificity Therapeutic Targeting
por: Rosenfeld, Simon
Publicado: (2011)

30 YEARS OF THE MINERALOCORTICOID RECEPTOR: Mineralocorticoid receptor antagonists: 60 years of research and development
por: Kolkhof, Peter, et al.
Publicado: (2017)

The Time to Reconsider Mineralocorticoid Receptor Blocking Strategy: Arrival of Nonsteroidal Mineralocorticoid Receptor Blockers
por: Tezuka, Yuta, et al.
Publicado: (2022)

Expression of genes encoding mineralocorticoid biosynthetic enzymes and the mineralocorticoid receptor, and levels of mineralocorticoids in the bovine follicle and corpus luteum
por: MUKANGWA, Memory, et al.
Publicado: (2019)

Structural analysis of the evolution of steroid specificity in the mineralocorticoid and glucocorticoid receptors
por: Baker, Michael E, et al.
Publicado: (2007)

Vascular cell-specific roles of mineralocorticoid receptors in pulmonary hypertension
por: Menon, Divya P., et al.
Publicado: (2021)

Recent advances and future directions in preclinical research of arginine-vasopressin (AVP) receptor blocker conivaptan in the context of stroke
por: Zeynalov, Emil, et al.
Publicado: (2016)

Immune Mechanisms in Vascular Disease and Stroke
por: Toh, Ban-Hock, et al.
Publicado: (2014)

Mineralocorticoid receptor blockade for renoprotection
por: Cha, Dae Ryong
Publicado: (2018)

Astrocytic aquaporin 4 subcellular translocation as a therapeutic target for cytotoxic edema in ischemic stroke
por: Patabendige, Adjanie, et al.
Publicado: (2022)

The presence of functional blood vessels in the ischemic core provides a therapeutic target for stroke recovery
por: Morris, Gary P., et al.
Publicado: (2023)

Importance of Micromilieu for Pathophysiologic Mineralocorticoid Receptor Activity—When the Mineralocorticoid Receptor Resides in the Wrong Neighborhood
por: Griesler, Bruno, et al.
Publicado: (2022)

Mineralocorticoid Receptor-Associated Mechanisms in Diabetic Kidney Disease and Clinical Significance of Mineralocorticoid Receptor Antagonists
por: Mende, Christian W., et al.
Publicado: (2023)

Glial cells in the center of future ischemic stroke treatments
por: Hernández, Ivó H., et al.
Publicado: (2022)

Myeloid Mineralocorticoid Receptor During Experimental Ischemic Stroke: Effects of Model and Sex
por: Frieler, Ryan A., et al.
Publicado: (2012)

Current AQP research: therapeutic approaches to ischemic and hemorrhagic stroke
por: Ma, Linlin, et al.
Publicado: (2016)

Aldosterone and the mineralocorticoid receptor in renal injury: A potential therapeutic target in feline chronic kidney disease
por: Spencer, Sarah, et al.
Publicado: (2020)

COVID-19 therapeutics: Challenges and directions for the future
por: Robinson, Philip C., et al.
Publicado: (2022)

Neutrophil in diabetic stroke: emerging therapeutic strategies
por: Kumari, Rashmi, et al.
Publicado: (2021)

Principal function of mineralocorticoid signaling suggested by constitutive knockout of the mineralocorticoid receptor in medaka fish
por: Sakamoto, Tatsuya, et al.
Publicado: (2016)

Flow cytometry and stroke: from current methodology to future applications
por: Amu, Sylvie, et al.
Publicado: (2022)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Localization of Mineralocorticoid Receptors at Mammalian Synapses
por: Prager, Eric M., et al.
Publicado: (2010)

Aldosterone and Mineralocorticoid Receptors—Physiology and Pathophysiology
por: Funder, John W.
Publicado: (2017)

Future directions for medicinal chemistry in the field of oligonucleotide therapeutics
por: Hall, Jonathan
Publicado: (2023)

The future of sickle cell disease therapeutics rests in genomics
por: Wonkam, Ambroise
Publicado: (2023)

Modulation of Immunity and Inflammation by the Mineralocorticoid Receptor and Aldosterone
por: Muñoz-Durango, N., et al.
Publicado: (2015)

Proteasome inhibition reduces plasma cell and antibody secretion, but not angiotensin II-induced hypertension
por: Figueiredo Galvao, Hericka Bruna, et al.
Publicado: (2023)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2jrpud5a9qp9sld2es0d3vtmsp